PRIMARY SJÖGREN'S SYNDROME
Clinical trials for PRIMARY SJÖGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJÖGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Follow-Up trial checks safety of promising Sjögren's syndrome drug
Disease control CompletedThis study aimed to check the long-term safety of the drug efgartigimod in adults with primary Sjögren's syndrome. It included 24 participants who had already finished a previous efgartigimod trial and chose to continue treatment. The main goal was to monitor for side effects ove…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First human tests begin for new Sjogren's syndrome drug
Disease control CompletedThis early-stage study tested a new drug called IBI355 in 30 adults with primary Sjogren's syndrome, an autoimmune disease that causes dry eyes and mouth. The main goal was to check how safe the drug is and how the body processes it when given in increasing doses. Researchers als…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC